000 01370 a2200385 4500
005 20250515160748.0
264 0 _c20090617
008 200906s 0 0 eng d
022 _a1387-2877
024 7 _a10.3233/JAD-2009-0965
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLópez-Bastida, Julio
245 0 0 _aCost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease.
_h[electronic resource]
260 _bJournal of Alzheimer's disease : JAD
_c2009
300 _a399-407 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aCholinesterase Inhibitors
_xeconomics
650 0 4 _aCost-Benefit Analysis
_xeconomics
650 0 4 _aDisease Progression
650 0 4 _aDonepezil
650 0 4 _aHumans
650 0 4 _aIndans
_xeconomics
650 0 4 _aMarkov Chains
650 0 4 _aPiperidines
_xeconomics
650 0 4 _aQuality of Life
650 0 4 _aSensitivity and Specificity
650 0 4 _aSpain
_xepidemiology
650 0 4 _aTreatment Outcome
700 1 _aHart, Warren
700 1 _aGarcía-Pérez, Lidia
700 1 _aLinertová, Renata
773 0 _tJournal of Alzheimer's disease : JAD
_gvol. 16
_gno. 2
_gp. 399-407
856 4 0 _uhttps://doi.org/10.3233/JAD-2009-0965
_zAvailable from publisher's website
999 _c18664367
_d18664367